Etiometry 2025 Highlights and Looking Ahead to 2026

Blog

Etiometry is proud to celebrate a year of meaningful achievements in 2025, driven by close collaboration and a shared commitment to improving patient care.
In 2025, Etiometry achieved significant momentum in advancing AI-driven clinical intelligence and supporting critical care teams:

2025 Highlights:

  • Delivered major platform advancements and expanded hospital adoption, informing the care of more than 425,000 patients to date.
  • Secured our 10th FDA clearance, validating enhanced cybersecurity protections for hospitals and patients.
  • Advanced the platform with deeper incorporation of high-resolution waveform data, enabling richer physiological insights at the point of care.
  • Earned the 2025 Digital Health Hub Award – Best in Class: AI in Patient Care at the HLTH conference.
  • Published a record number of clinical studies with leading institutions, strengthening evidence across pediatric and adult critical care.
  • Continued focus on our Cardiac Critical Care Solution, supporting clinicians by organizing and displaying patient data to aid decision-making in intensive care settings.
  • Added the highest number of hospitals in company history, with notable growth among major health systems.
  • Expanded internationally, strengthening our presence in Europe and the Middle East through strategic partnerships.

As Shane Cooke, President and CEO of Etiometry, noted, the platform plays a proven role in improving care quality, reducing length of stay and ICU readmissions, lowering costs, easing care team burden, and improving documentation of complications.


Looking Ahead to 2026:

We are building on this momentum with a clear focus on:

  • Expanding our presence in the adult cardiac market.
  • Accelerating international expansion in Europe and the Middle East.
  • Continuing to advance solutions to help identify and manage life-threatening conditions, including cardiogenic shock, respiratory failure, and sepsis/ARDS.


With appreciation,
The Etiometry Team

Related

New study shows how IDO2 index could help bring attention to changes in patient risk sooner.  New data in Adult patients.

In intensive care settings, most serious deterioration develops gradually rather than suddenly, with abnormal vital signs detectable hours before significant events. This means that clinicians must monitor subtle physiologic changes to support timely assessment and decision-making.1,2 However, continuous physiologic and laboratory monitoring generates vast amounts of data, and clinicians must constantly decide which signals warrant […]

How Clinical Intelligence Software Supports ICU Decision-Making

In today’s increasingly complex ICU environments, clinicians are tasked with managing massive amounts of physiologic data under tight time constraints. Etiometry’s clinical intelligence software offers a powerful solution—an FDA-cleared, AI-driven clinical intelligence tool designed to augment clinical decision-making in critical care.  This article outlines Etiometry’s clinical intelligence software personalized hemodynamic and respiratory care strategies, improving […]